Can Fite Biopharma Ltd

Can Fite Biopharma Ltd

Health CarePharmaceuticals and Biotechnology
  • Price (USD)0.8549
  • Today's Change0.015 / 1.76%
  • Shares traded78.33k
  • 1 Year change-60.05%
  • Beta--
Data delayed at least 15 minutes, as of May 26 2022 19:01 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

Institutional shareholders

1.40%Per cent of shares held by top holders
HolderShares% Held
Morgan Stanley & Co. LLCas of 31 Mar 2022304.18k1.12%
Fifth Third Bank, NA (Investment Management)as of 31 Mar 202230.00k0.11%
Stifel Nicolaus & Co., Inc. (Investment Management)as of 31 Mar 202212.00k0.04%
Citadel Advisors LLCas of 31 Mar 202211.33k0.04%
UBS Securities LLCas of 31 Mar 20227.18k0.03%
National Bank Financial, Inc.as of 31 Mar 20226.00k0.02%
Citigroup Global Markets, Inc. (Investment Management)as of 31 Mar 20225.54k0.02%
CapFinancial Partners LLCas of 31 Mar 20221.55k0.01%
Wells Fargo Clearing Services LLCas of 31 Mar 20221.50k0.01%
Merrill Lynch, Pierce, Fenner & Smith, Inc. (Invt Mgmt)as of 31 Mar 2022366.000.00%
More ▼
Data from 31 Mar 2022 - 31 Mar 2022Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.